The U.S. Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply ...

MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...

The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...

K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies ...

In line with the Trump administration’s goal to curb the United States’ reliance on overseas drug manufacturing, the FDA has ...

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target ...

The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug ...

As the federal government pushes for lower drug prices and more domestic production, the FDA launched a “PreCheck” program Aug. 7 to expedite approval of new U.S. drug manufacturing facilities.  FDA ...

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized ...

Obstructive sleep apnea severity measured via apnea-hypopnea index decreased among patients receiving AD109, an oral ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...